Open AccessThe Impact of Prescription Medication Cost Coverage on Oral Medication Use for Hypertension and Type 2 Diabetes Mellitus
Author(s) -
Razan Amoud,
Kelly Grindrod,
Martin Cooke,
Mhd Wasem Alsabbagh
Publication year - 2020
Publication title -
healthcare policy
Language(s) - English
Resource type - Journals
eISSN - 1715-6580
pISSN - 1715-6572
DOI - 10.12927/hcpol.2020.26351
Subject(s) - medical prescription , medicine , diabetes mellitus , medication adherence , type 2 diabetes mellitus , health insurance , type 2 diabetes , family medicine , health care , pharmacology , endocrinology , economic growth , economics
No previous study, to the best of our knowledge, has examined both the time trend and impact of not having insurance or prescription medication cost coverage (PMCC) on the usage of type 2 diabetes and hypertension oral medications in Ontario and New Brunswick, Canada.